Mariko Nagashima

Title: Mariko Nagashima: Innovator in Thrombomodulin Analog Research

Introduction

Mariko Nagashima is a prominent inventor based in Belmont, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombomodulin analogs. With a total of 4 patents to her name, her work is paving the way for advancements in antithrombotic therapy.

Latest Patents

One of her latest patents focuses on thrombomodulin analogs for pharmaceutical use. This invention relates to the design, production, and use of analogs of thrombomodulin (TM) that enhance the thrombin-mediated activation of protein C. Importantly, these analogs have a significantly reduced ability to promote the activation of thrombin-activatable fibrinolysis inhibitor (TAFI). This innovation is particularly useful in antithrombotic therapy, showcasing her commitment to improving medical treatments.

Career Highlights

Mariko Nagashima is currently associated with Schering Aktiengesellschaft, where she continues her research and development efforts. Her work has garnered attention in the pharmaceutical industry, highlighting her expertise and innovative approach to solving complex medical challenges.

Collaborations

Throughout her career, Mariko has collaborated with notable professionals, including Michael John Morser and David Richard Light. These collaborations have further enriched her research and contributed to her success in the field.

Conclusion

Mariko Nagashima's contributions to thrombomodulin analog research exemplify her dedication to innovation in pharmaceuticals. Her work not only enhances our understanding of antithrombotic therapies but also demonstrates the impact of her inventions on medical science.